“Streamlining the Path to Commercial Success for Cell Therapy”

Cenk Sumen of PCT Cell Therapy Services  joined us for Stem Cells & Regenerative Medicine Congress USA 2014 to present about ‘ Streamlining the Path to Commercial Success for Cell Therapy”   Download the presentation now to understand more about: Typical CAR T cell manufacturing process Technology examples for separation/volume reduction   Manufacturing constraints Unique manufacturing challenges for autologous processes …and much more! Get your …

Stem Cells Live: What is the Most Expensive Unit Operation Step in your Process?

“The one you need to change “, says Bob Preti, President and CSO of Progenitors Cell Therapy, “ And the later in the clinical development you change it the more expensive it is going to be”. Bob talks about the Developed by Design approach he developed at PCT, a leading US-based contract manufacturing organization in the afternoon session, which Dave …